Kiera Keegan, NP

Bradley B. Pua, M.D.Chief, Division of Interventional Radiology Director, Lung Cancer Screening Program Director, Radiology Consultation ServicesDr. Bradley Pua is a nationally recognized leader in Interventional Radiology, known for advancing multidisciplinary care, early cancer detection, and procedural innovation. He earned his B.S. in Chemistry from New York University (NYU) and completed his M.D. at NYU School of Medicine. After three years of surgical residency at NYU Medical Center, he trained in Interventional Radiology through a fellowship at NewYork-Presbyterian/Weill Cornell and Memorial Sloan Kettering Cancer Center. He completed his diagnostic radiology residency at Cornell, serving as Chief Resident.Dr. Pua’s clinical practice includes a wide range of image-guided therapies such as embolization, stent placement, tumor ablation, biopsy, and vascular access. His focus areas include pediatric interventions and minimally invasive cancer therapy, with particular expertise in thoracic tumors.He co-founded a multidisciplinary vascular anomalies team that provides coordinated, longitudinal care for patients with hemangiomas, arteriovenous malformations, venous anomalies, and lymphatic disorders.As Director of the Lung Cancer Screening Program, Dr. Pua has streamlined diagnostic and therapeutic pathways for pulmonary nodules, accelerating access to curative treatment. He leads and collaborates on multiple clinical trials focused on minimally invasive lung tumor treatment, utilizing advanced techniques such as radiofrequency, microwave, cryoablation, and pulsed electric field ablation.A champion of emerging technology, Dr. Pua integrates augmented reality (AR) solutions into procedural planning and image-guided interventions. His work explores how AR overlays can enhance precision, safety, and outcomes across interventional oncology and complex vascular treatments.https://www.cbsnews.com/newyork/news/how-2-new-yorkers-are-tipping-the-odds-of-lung-cancer-survival/

Deborah Smith is an Assistant Professor of Radiation Oncology at Weill Cornell Medicine. She graduated Phi Beta Kappa from Brown University and received her medical degree Alpha Omega Alpha from the Columbia University Vagelos College of Physicians and Surgeons. She completed her medical internship and residency training as well as chief residency at Memorial Sloan Kettering Cancer Center before joining the faculty at Weill Cornell.

Dr. Cynthia Tsay is an Assistant Professor of Medicine at Weill Cornell Medicine and New York-Presbyterian Hospital and a general gastroenterologist with a clinical and research interest in early gastric cancer, gastric intestinal metaplasia, and other conditions involving the stomach. She is interested in the application of machine learning and artificial intelligence in the risk stratification and early detection of premalignant lesions in high risk populations, as well as the role of the microbiome in these conditions and ways in which medications alter the gastrointestinal microbiome. She has published in Gastroenterology, Clinical Gastroenterology and Hepatology, Alimentary Pharmacology & Therapeutics and the American Journal of Gastroenterology. She obtained her B.A. in the History of Science and the History of Medicine at Yale College and her M. Phil in the History, Philosophy, and Sociology of Science, Medicine, and Technology at the University of Cambridge. Dr. Tsay returned to New Haven where she earned her M.D. at the Yale School of Medicine and completed her residency in Internal Medicine at Yale New Haven Hospital. She also has a M.P.H in Epidemiology from the Harvard T.H. Chan School of Public Health. She completed her fellowship training in Gastroenterology and Hepatology at the Johns Hopkins Hospital where she served as chief fellow during her last two years. Dr. Tsay is also passionate about medical education and the experience of trainees, having served as president of the Yale Resident and Fellow Senate and the chair of the Johns Hopkins Clinical Fellows Council.